Close Menu

NEW YORK (GenomeWeb) – Swedish diagnostic developer Immunovia said today that it has established a US subsidiary in Boston. The facility will house a CLIA reference lab and commercialization operations for the firm, which is preparing to launch its first test — a liquid biopsy assay for pancreatic cancer called Immray PanCan-d — in the first half of 2018.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Mar
28
Sponsored by
Qiagen

The Human Gene Mutation Database (HGMD) is a manually curated, comprehensive collection of disease-causing, germline mutations. Since 1996, a team of experts has manually catalogued over a quarter of a million mutations for the database.  

Apr
09
Sponsored by
Sophia Genetics

This webinar will present the utility of a personalized in silico analytical approach for the routine clinical diagnosis of channelopathies and cardiomyopathies.